Retatrutide 6mg
£60.00
Pound sterling (£) - GBP
The 6mg dose refers to a specific strength of this medication, which is administered as a once-weekly subcutaneous injection. In phase 2 clinical trials, participants on weekly doses of retatrutide experienced significant weight loss. Some studies show an average weight loss of up to 24% after about 11-18 months of treatment with higher doses. It is important to note that retatrutide is still in the experimental stages and has not yet been approved by the FDA or other regulatory agencies.Â
Dosage and administration
- Retatrutide is given as a once-weekly subcutaneous injection.
- Dosages are typically started low and gradually increased.
- The maximum weekly dose in studies has been up to 12mg or 16mg.Â
Potential benefits
- Significant Weight Loss:Â Clinical trials have shown promising results in terms of weight loss, with some studies demonstrating weight reductions of up to 24.2% over 48 weeks with higher doses.
- Improved Blood Sugar Control:Â By activating GLP-1 and GIP receptors, retatrutide helps regulate blood sugar levels, potentially beneficial for individuals with prediabetes or type 2 diabetes.
- Better Metabolic Health:Â Retatrutide’s multifaceted approach may lead to improvements in various metabolic markers, including blood pressure, cholesterol levels, and liver fat content.Â
Potential side effects
- Gastrointestinal Issues:Â The most common side effects reported are gastrointestinal, such as nausea, vomiting, diarrhea, and constipation, especially during the initial weeks and with dose increases.
- Other side effects:Â Less common side effects include dizziness, abdominal pain, fatigue, and injection site reactions. Some studies have also reported heart rate increases, cardiac arrhythmias, and heightened skin sensitivity.
- Serious side effects are rare:Â But include pancreatitis or severe allergic reactions.Â
Important considerations
- Retatrutide is not yet FDA approved and should only be used in research settings at this time.
- Consult with a healthcare professional before considering any new weight loss therapy or medication.
- Individuals with certain health conditions or a history of medullary thyroid cancer or multiple endocrine neoplasias type 2 should not use these drugs.Â
- Significant Weight Loss:Â Clinical trials have shown promising results in terms of weight loss, with some studies demonstrating weight reductions of up to 24.2% over 48 weeks with higher doses.
- Improved Blood Sugar Control:Â By activating GLP-1 and GIP receptors, retatrutide helps regulate blood sugar levels, potentially beneficial for individuals with prediabetes or type 2 diabetes.
We offer complimentary express shipping.
Free returns are available worldwide. If your item is eligible for return, you have 30 days from the date you receive your order to follow this procedure.
See delivery and returns for more information.
Shop The Look
